Olanzapine as antiemetic prophylaxis in chemotherapy
Elisa Agostinetto shared on X:
“Olanzapine as antiemetic prophylaxis in chemotherapy. In this randomized phase 3 study the addition of olanzapine to dexamethasone, palonosetron, and aprepitant improved emesis control in patients receiving moderately emetogenic CT.”
Authors: Vikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, Prabhat Bhargava, Deepali Naughane, Sharon Flavia Sunn, Sujay Srinivas, Akhil Kapoor, Bal Krishna Mishra, Anuj Gupta, Bipinesh Sansar, Vikash Pal, Aparajita Pandey, Avinash Bonda, Indraja Siripurapu, Vamshi Krishna Muddu, Sadhana Kannan, Deepali Chaugule, Rajshree Patil, Manali Parulekar, Aditya Dhanawat, Mehek Trikha, Jaya Ghosh, Vanita Noronha, Nandini Menon, Vijay Patil, Kumar Prabhash, Ian Olver.
Source: Elisa Agostinetto/X
Dr. Elisa Agostinetto, is a medical oncologist, specializing in breast cancer research. Elisa Agostinetto is a Medical Research Fellow at the University Hospital of Brussels since November 2021. Additionally, she has serves as a Clinical Research Fellow at Jules Bordet Institute. Her work focuses on clinical research in oncology, likely involving various aspects of cancer treatment and patient care.
Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023